Vertex Pharmaceuticals Incorporated (VRTX)
USD 447.5
(-4.63%)
USD 447.5
(-4.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.86 Billion | 8.93 Billion | 7.57 Billion | 6.2 Billion | 4.16 Billion | 3.04 Billion |
| Cost of Revenue | 1.26 Billion | 1.08 Billion | 904.2 Million | 736.3 Million | 547.75 Million | 409.53 Million |
| Gross Profit | 8.6 Billion | 7.85 Billion | 6.67 Billion | 5.46 Billion | 3.61 Billion | 2.63 Billion |
| Operating Expenses | 4.77 Billion | 3.48 Billion | 3.89 Billion | 2.59 Billion | 2.41 Billion | 1.97 Billion |
| Selling, General and Administrative Expenses | 1.13 Billion | 944.7 Million | 840.1 Million | 770.45 Million | 658.49 Million | 557.61 Million |
| Research and Development Expenses | 3.16 Billion | 2.54 Billion | 3.05 Billion | 1.82 Billion | 1.75 Billion | 1.41 Billion |
| Other Expenses | 475.5 Million | -164.8 Million | 4.9 Million | 296.42 Million | 192.17 Million | -790 Thousand |
| Cost and Expenses | 6.03 Billion | 4.56 Billion | 4.79 Billion | 3.33 Billion | 2.96 Billion | 2.38 Billion |
| Operating Income | 4.3 Billion | 4.3 Billion | 2.78 Billion | 2.85 Billion | 1.19 Billion | 635.15 Million |
| Interest Expense | 44.1 Million | 54.8 Million | 61.5 Million | 58.15 Million | 58.5 Million | 34.11 Million |
| Income Tax Expense | 760.2 Million | 910.4 Million | 388.3 Million | 405.15 Million | 218.1 Million | -1.48 Billion |
| Earnings before Tax | 4.37 Billion | 4.23 Billion | 2.73 Billion | 3.11 Billion | 1.39 Billion | 600.24 Million |
| Net Income | 3.61 Billion | 3.32 Billion | 2.34 Billion | 2.71 Billion | 1.17 Billion | 2.09 Billion |
| Earnings Per Share Basic | 14.05 | 12.97 | 9.09 | 10.44 | 4.58 | 8.25 |
| Earnings Per Share Diluted | 13.89 | 12.82 | 9.01 | 10.29 | 4.51 | 8.09 |
| Weighted Average Shares Outstanding | 257.7 Million | 256.1 Million | 257.7 Million | 259.84 Million | 256.72 Million | 254.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 260.5 Million | 259.1 Million | 259.89 Million | 263.39 Million | 260.67 Million | 259.18 Million |
| Gross Margin | 0.87 | 0.88 | 0.88 | 0.88 | 0.87 | 0.87 |
| EBIT Margin | 0.47 | 0.49 | 0.37 | 0.51 | 0.35 | 0.22 |
| Profit Margin | 0.37 | 0.37 | 0.31 | 0.44 | 0.28 | 0.69 |
| EBITDA | 4.6 Billion | 4.43 Billion | 2.91 Billion | 3.28 Billion | 1.56 Billion | 706.78 Million |
| Earnings Before Tax Margin | 0.44 | 0.48 | 0.37 | 0.46 | 0.29 | 0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.77 Billion | 2.63 Billion | 2.68 Billion | 9.83 Billion | 2.51 Billion | 2.48 Billion |
| Cost of Revenue | 392.6 Million | 371.9 Million | 342.6 Million | 1.26 Billion | 368 Million | 318.7 Million |
| Gross Profit | 2.37 Billion | 2.26 Billion | 2.34 Billion | 8.57 Billion | 2.14 Billion | 2.16 Billion |
| Operating Expenses | 1.26 Billion | 5.78 Billion | 1.2 Billion | 4.82 Billion | 1.19 Billion | 1.07 Billion |
| Selling, General and Administrative Expenses | 371.8 Million | 372.2 Million | 342.7 Million | - | 369.1 Million | 263.8 Million |
| Research and Development Expenses | 875.9 Million | 5.41 Billion | 865.9 Million | - | 821.8 Million | 810 Million |
| Other Expenses | 15.3 Million | -23.1 Million | -31.2 Million | -22.8 Million | -9.8 Million | -15.9 Million |
| Cost and Expenses | 1.65 Billion | 6.15 Billion | 1.55 Billion | 6.08 Billion | 1.55 Billion | 1.39 Billion |
| Operating Income | 1.11 Billion | -3.52 Billion | 1.13 Billion | 3.75 Billion | 958.8 Million | 1.03 Billion |
| Interest Expense | -7.5 Million | 9.9 Million | 10.4 Million | 44.1 Million | 10.6 Million | 10.9 Million |
| Income Tax Expense | 178.7 Million | 202.4 Million | 179.5 Million | 760.2 Million | 178.8 Million | 143.9 Million |
| Earnings before Tax | 1.22 Billion | -3.39 Billion | 1.27 Billion | 4.37 Billion | 1.14 Billion | 1.17 Billion |
| Net Income | 1.04 Billion | -3.59 Billion | 1.09 Billion | 3.61 Billion | 968.8 Million | 1.03 Billion |
| Earnings Per Share Basic | 4.05 | -13.92 | 4.26 | - | 3.76 | 4.01 |
| Earnings Per Share Diluted | 4.01 | -13.92 | 4.21 | - | 3.71 | 3.97 |
| Weighted Average Shares Outstanding | 258 Million | 258.1 Million | 258.2 Million | 257.7 Million | 257.7 Million | 258 Million |
| Weighted Average Shares Outstanding (Diluted) | 261 Million | 258.1 Million | 261.1 Million | 260.5 Million | 260.89 Million | 260.6 Million |
| Gross Margin | 0.86 | 0.86 | 0.87 | 0.87 | 0.85 | 0.87 |
| EBIT Margin | 0.40 | -1.32 | 0.44 | - | 0.40 | 0.50 |
| Profit Margin | 0.38 | -1.36 | 0.41 | 0.37 | 0.38 | 0.42 |
| EBITDA | 1.11 Billion | -3.47 Billion | 1.18 Billion | - | 1.01 Billion | 1.24 Billion |
| Earnings Before Tax Margin | 0.40 | -1.34 | 0.42 | 0.38 | 0.38 | 0.42 |
MANAKSIA
0180
SUVEN
FAAS
BLMIF
COUNCODOS